Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
Improving the Bladder Cancer Survivorship for Women
Cleveland Clinic Cancer Advances
14 minutes
4 months ago
Improving the Bladder Cancer Survivorship for Women
Laura Bukavina, MD, MPH, a Urologic Oncologist and Translational Research Lead for genitourinary oncology at Cleveland Clinic joins the Cancer Advances Podcast to talk about strategies to improve the survivorship experience for women with bladder cancer, including treatment advances, quality-of-life considerations and encouraging open conversations to drive better survivorship programs.
Cleveland Clinic Cancer Advances
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
